Reply to Cossu et al., "Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV"

MeSH terms

• Anti-HIV Agents* / administration & dosage
• Anti-HIV Agents* / pharmacokinetics
• Anti-HIV Agents* / therapeutic use
• Diketopiperazines*
• HIV Infections* / drug therapy
• Humans
• Injections, Intramuscular
• Pyridones* / administration & dosage
• Pyridones* / pharmacokinetics
• Pyridones* / therapeutic use
• Rilpivirine* / pharmacokinetics
• Rilpivirine* / therapeutic use